World's Best Scientists 2026 revealed!
Christian Hartmann

Christian Hartmann

D-Index & Metrics

Medicine

D-Index
83
Citations
29157
World Ranking
15489
National Ranking
817

Overview

Christian Hartmann is affiliated with Hannover Medical School in Germany. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in the subfields of Molecular Biology, Neurology, Genetics, Epidemiology, and Pulmonary and Respiratory Medicine.

Their main topics of work include:

  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Chromatin Remodeling and Cancer
  • Neurological disorders and treatments
  • Sarcoma Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • Meningioma and schwannoma management

Christian Hartmann has published extensively across several peer-reviewed venues. Among the most frequent publication venues are:

  • Neuro-Oncology
  • Acta Neuropathologica
  • Frontiers in Neurology
  • Neuropathology and Applied Neurobiology
  • Journal of Neurology

They have coauthored many works with several frequent collaborators, including:

  • Joachim K. Krauss
  • Martin Hasselblatt
  • Andreas von Deimling
  • Stefan M. Pfister
  • Felix Sahm

Recent papers authored or coauthored by Christian Hartmann include:

  • Sarcoma classification by DNA methylation profiling, 2021, Nature Communications
  • Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort, 2020, Journal of Clinical Oncology
  • Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis, 2020, Acta Neuropathologica
  • Infratentorial IDH-mutant astrocytoma is a distinct subtype, 2020, Acta Neuropathologica
  • Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma, 2020, Cancers

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

    Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang

  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

    Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

    Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper

  • Analysis of the IDH1 codon 132 mutation in brain tumors

    Jörg Balss;Jochen Meyer;Wolf Mueller;Andrey Korshunov;Andrey Korshunov

  • Long-term survival with glioblastoma multiforme

    Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

    Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels

  • Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

    Michael Weller;Jörg Felsberg;Christian Hartmann;Hilmar Berger

  • Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

    David Capper;Susanne Weißert;Jörg Balss;Antje Habel

  • Monoclonal antibody specific for IDH1 R132H mutation.

    David Capper;Hanswalter Zentgraf;Jörg Balss;Christian Hartmann;Christian Hartmann

  • Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

    Brigitta G Baumert;Brigitta G Baumert;Monika E Hegi;Martin J van den Bent;Andreas von Deimling

  • Sarcoma classification by DNA methylation profiling

    Christian Koelsche;Christian Koelsche;Daniel Schrimpf;Daniel Schrimpf;Damian Stichel;Martin Sill

  • IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO

    David E. Reuss;David E. Reuss;Yasin Mamatjan;Daniel Schrimpf;Daniel Schrimpf;David Capper;David Capper

  • Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma

    Andrey Korshunov;Andrey Korshunov;Jochen Meyer;David Capper;Arne Christians

  • Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.

    Felix Sahm;Felix Sahm;David Reuss;David Reuss;Christian Koelsche;Christian Koelsche;David Capper;David Capper

  • Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

    Christian Koelsche;Christian Koelsche;Felix Sahm;Felix Sahm;David Capper;David Capper;David Reuss;David Reuss

  • Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.

    David E. Reuss;Rosario M. Piro;Rosario M. Piro;David T. W. Jones;Matthias Simon

  • Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas

    M. Kunz;N. Thon;S. Eigenbrod;C. Hartmann

  • Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.

    Michael Weller;Ruthild G. Weber;Edith Willscher;Vera Riehmer

Frequent Co-Authors

Andreas von Deimling
Andreas von Deimling Heidelberg University
Felix Sahm
Felix Sahm University Hospital Heidelberg
David Capper
David Capper Charité - University Medicine Berlin
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Guido Reifenberger
Guido Reifenberger Heinrich Heine University Düsseldorf
Michael Weller
Michael Weller University of Zurich
Christel Herold-Mende
Christel Herold-Mende Heidelberg University
David T. W. Jones
David T. W. Jones German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but are seeking flexible options, numerous online degrees can set you on the right path. For nursing, many students look for affordable programs to help manage costs. There are a variety of cheapest np programs online for those who wish to become Nurse Practitioners, a growing field with strong job prospects.

Aspiring nurses can also explore affordable online nursing programs, making it possible to start a nursing career without excessive debt. Registered nurses seeking to expand their credentials can benefit from cheap rn to bsn online programs, which allow them to advance professionally while balancing work and other commitments.

For those interested in academic or leadership roles within nursing, there are also online phd programs nursing that offer advanced study and research opportunities. These affordable online pathways can open doors to specialized careers and leadership positions in healthcare.

Best Scientists Citing Christian Hartmann

Trending Scientists

Recently Published Articles